(Q28165363)

English

Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms

scientific article (publication date: 17 September 2003)

In more languages

Statements

scholarly article

0 references

Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms (English)

0 references

1 reference

based on heuristic

inferred from title

author name string

Laurent Macchi

1

0 references

Luc Christiaens

2

0 references

Severine Brabant

3

0 references

Nathalie Sorel

4

0 references

Stephanie Ragot

5

0 references

Joseph Allal

6

0 references

Gérard Mauco

7

0 references

André Brizard

8

0 references

language of work or name

0 references

publication date

17 September 2003

0 references

Journal of the American College of Cardiology

0 references

42

0 references

6

0 references

1115-9

0 references

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet polymorphisms in thrombotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Human platelet-specific alloantigens: update

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein polymorphisms as risk factors for thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

PlA2 polymorphism and efficacy of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

PFA-100 system: a new method for assessment of platelet dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIIa gene polymorphism and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of eryt

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic optimisation of the treatment of embolic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Pl(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900921-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(03)00921-5

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28165363&oldid=1408742644"